'Synthetic pot' sending thousands of young people to ER

December 4, 2012 by Alan Mozes, Healthday Reporter in Addiction

SAMHSA: >11,000 ER visits for synthetic marijuana in 2010

In 2010, more than 11,000 emergency department visits involved a synthetic cannabinoid product (synthetic marijuana, commonly known by street names including "Spice" and "K2"), 75 percent of which were among those aged 12 to 29 years, according to a report published Dec. 4 by the Substance Abuse and Mental Health Services Administration.

(HealthDay)—U.S emergency rooms tended to more than 11,400 cases of drug-related health complications specifically linked to the use of synthetic marijuana in 2010, a new government report reveals.

Released Tuesday, The DAWN Report from the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) attaches a hard figure to the potential health risks associated with the growing use of synthetic marijuana. The report also puts such use in context, observing, for example, that actual marijuana use accounted for far more ER visits (exceeding 461,000) in the same time frame.

"It's not an epidemic," acknowledged Rear Admiral Peter Delany, director of SAMHSA's Center for Behavioral Health Statistics and Quality. "But it's a growing problem. And people need to be thinking about it, and how we're going to deal with it."

Since it first came on the scene in the United States in 2008, synthetic marijuana has commonly been sold, with a wink and a nod, under the guise of being an innocuous "herbal incense," according to the White House Office of National Drug Control Policy.

Until recently, however, customers have sought it out—under names like "Spice" and "K2" —as a legal alternative to real marijuana, based on its reputation as being able to prompt a similar high.

But though it's varying ingredients are typically sprayed in liquid form on top of plant materials, such so-called "fake" marijuana is exactly that: an entirely synthesized and unlabeled chemical concoction, rather than a naturally grown plant.

In the last few years, synthetic marijuana has seen a rapid increase in popularity, particularly among American teens who initially could turn to local convenience stores and the Internet for legal access. The authors of the report point to a 2011 drug-use study that found that more than 11 percent of high school seniors admitted having tried the drug in the prior year.

In light of such numbers, health risk concerns led to sales restrictions in 38 states, and in the summer of 2012 the U.S. Food and Drug Administration imposed a wholesale ban on all sales of synthetic cannabinoids.

The current SAMHSA report uses public health surveillance data on all 2.3 million drug abuse or misuse-related visits to U.S emergency departments in 2010 involving both male and female patients between the ages of 12 and 29 (who account for the bulk of users).

Male patients made up 78 percent of synthetic pot emergencies, the report team noted, compared with 66 percent among authentic marijuana emergencies.

Most (59 percent) of those seeking emergency care following synthetic marijuana use were not using any other drug at the time, while 36 percent had used it in conjunction with one other drug such as actual marijuana, alcohol or prescription drugs.

Most of the synthetic pot patients were ultimately discharged directly from the ER, with less than one-quarter requiring follow-up care after their initial visit, the report noted.

Nevertheless, Delany pointed out that the host of complications that can land a synthetic pot user in the emergency department in the first place are not to be taken lightly.

"I think parents and communities need to become more informed about this drug," Delany said. "They should be aware that you don't know what you're buying when you buy it. You don't know the potency and the chemical compound. And they should also know that young people who use it are ending up in the ER, due to high blood pressure, nausea, vomiting, anxiety, agitation and sometimes seizures. So you can't say this is a safe drug. Especially if you decide to mix it with other chemicals."

The thought is seconded by Dr. Adam Bisaga, a professor of psychiatry at Columbia University and an addiction psychiatrist with the New York State Psychiatric Institute.

"Certainly in the context of other forms of drug abuse, the numbers they show here related to synthetic marijuana are nowhere near the numbers associated with, say, painkillers," Bisaga said.

"But with something sold as part of a 'spice package' you might think you're smoking herbs. And they're not herbs. You're not smoking tea or oregano. These are chemicals that are synthesized from scratch to act on the same receptors in the brain as real marijuana. But they are just pure chemicals, with no quality control and with the real potential to be toxic," he explained.

"So there was a time when selling them, and probably the use of them, was perceived as non-harmful," Bisaga noted. "But hopefully now, with the bans that have been put in place and the release of this kind of data, we are catching up to reality."

More information: For more on synthetic marijuana, visit the White House Office of National Drug Control Policy.

More Information

Copyright © 2012 HealthDay. All rights reserved.

not rated yet  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

Roland
Dec 05, 2012

Rank: not rated yet
This article is yet more pure propaganda. The term "synthetic pot" is slander of a natural product. Per this article: "you don't know what you're buying" with this stuff. It isn't regulated, precisely because it's banned. The best drug law ever passed was the Pure Food & Drug Act of 1907. It required honest labeling. People knew what they were taking. You see its effects today on some prescription drugs: "Warning: may be habit forming." Bans serve no purpose other than to make moralists feel superior. Legalize Cannabis, and problems described in the article simply disappear. ONDCP, stop LYING.
Rank not rated yet
Relevant PhysicsForums posts

More news stories

Beer-industry advertising guidelines: Rating panels may help industry assess itself

In order to avoid exposing vulnerable groups such as children and young adults to alcohol advertising, industry groups have developed their own self-regulation guidelines. However, these guidelines have been criticized for ...

Addiction created May 17, 2013 | popularity not rated yet | comments 0

College women exceed NIAAA drinking guidelines more frequently than college men

In order to avoid harms associated with alcohol consumption, in 2009 the National Institute on Alcohol Abuse and Alcoholism issued guidelines that define low-risk drinking. These guidelines differ for men and women: no more ...

Addiction created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast

Individuals who drink heavily and smoke may show 'early aging' of the brain

Treatment for alcohol use disorders works best if the patient actively understands and incorporates the interventions provided in the clinic. Multiple factors can influence both the type and degree of neurocognitive abnormalities ...

Addiction created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast

Researchers analyze how Spanish smoking relapse booklets are distributed

Researchers from Moffitt Cancer Center and the University of South Florida have evaluated how Florida health care and social service agencies distribute "Libres para Siempre", a Spanish smoking relapse prevention booklet ...

Addiction created May 17, 2013 | popularity not rated yet | comments 0

No significant change seen in overall smokeless tobacco use among US youths

Tobacco use remains the leading preventable cause of death and disease in the United States. Declines in smoking among youths were observed from the late 1990s. "However, limited information exists on trends in smokeless ...

Addiction created May 14, 2013 | popularity not rated yet | comments 0


Engineered cytomegalovirus protects monkeys from HIV equivalent

(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Hormone levels may provide key to understanding psychological disorders in women

Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.

Going live: Immune cell activation in multiple sclerosis

Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...

Driving and hands-free talking lead to spike in errors, study shows

Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.

Comorbidities common with alopecia areata

(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.